Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Scholze, Alexandra ^a   Bladbjerg, Else Marie ^b   Sidelmann, Johannes J ^b   Diederichsen, Axel C P ^a   Mickley, Hans ^a   Nybo, Mads ^a   Argraves, W Scott ^c   Marckmann, Peter ^a   Rasmussen, Lars M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Arterial stiffness; Cardiovascular disease; Diabetes; Fibulin 1; Kidney disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; FIBULIN; FIBULIN 1; HEMOGLOBIN A1C; INTERLEUKIN 6; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; AGING; APPLANATION TONOMETER; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; MALE; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SEROLOGY; TONOMETRY;

AGED; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UP-REGULATION;

EID: 84871887803     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-6     Document Type: Article

References (28)

1. Cangemi C, Skov V, Poulsen MK, Funder J, Twal WO, Gall MA, Hjortdal V, Jespersen ML, Kruse TA, Aagard J, Parving HH, Knudsen S, Høilund-Carlsen PF, Rossing P, Henriksen JE, Argraves WS, Rasmussen LM. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem 2011, 57:1556-1565. 10.1373/clinchem.2011.162966, 21926180.
2. Argraves WS, Greene LM, Cooley MA, Gallagher WM. Fibulins: physiological and disease perspectives. EMBO Rep 2003, 4:1127-1131. 10.1038/sj.embor.7400033, 1326425, 14647206.
3. Hungerford JE, Hoeffler JP, Bowers CW, Dahm LM, Falchetto R, Shabanowitz J, Hunt DF, Little CD. Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells. J Cell Biol 1997, 137:925-937. 10.1083/jcb.137.4.925, 2139835, 9151694.
4. Roark EF, Keene DR, Haudenschild CC, Godyna S, Little CD, Argraves WS. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem 1995, 43:401-411. 10.1177/43.4.7534784, 7534784.
5. Redfern CH, Degtyarev MY, Kwa AT, Salomonis N, Cotte N, Nanevicz T, Fidelman N, Desai K, Vranizan K, Lee EK, Coward P, Shah N, Warrington JA, Fishman GI, Bernstein D, Baker AJ, Conklin BR. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. PNAS 2000, 97:4826-4831. 10.1073/pnas.97.9.4826, 18317, 10781088.
6. Kruger R, Schutte R, Huisman HW, Argraves WS, Rasmussen LM, Olsen MH, Schutte AE. NT-proBNP is associated with fibulin-1 in Africans: The SAfrEIC study. Atherosclerosis 2012, 222:216-221. 10.1016/j.atherosclerosis.2012.01.045, 22349089.
7. Godyna S, Diaz-Ricart M, Argraves WS. Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood 1996, 88:2569-2577.
8. Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997, 8:320-328. 10.1097/00041433-199710000-00012, 9335957.
9. Tran H, Tanaka A, Litvinovich SV, Medved LV, Haudenschild CC, Argraves WS. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. J Biol Chem 1995, 270:19458-19464. 10.1074/jbc.270.33.19458, 7642629.
10. Argraves WS, Tanaka A, Smith EP, Twal WO, Argraves KM, Fan D, Haudenschild CC. Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol 2009, 132:559-565. 10.1007/s00418-009-0628-7, 19693531.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
12. Diederichsen AC, Sand NP, Nørgaard B, Lambrechtsen J, Jensen JM, Munkholm H, Aziz A, Gerke O, Egstrup K, Larsen ML, Petersen H, Høilund-Carlsen PF, Mickley H. Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Prev Cardiol 2012, 19:558-564. 10.1177/1741826711409172, 21525124.
13. Argraves WS, Dickerson K, Burgess WH, Ruoslahti E. Fibulin, a novel protein that interacts with the fibronectin receptor β subunit cytoplasmic domain. Cell 1989, 58:623-629. 10.1016/0092-8674(89)90097-4, 2527614.
14. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001, 38:932-937. 10.1161/hy1001.096106, 11641312.
15. Frimodt-Møller M, Nielsen AH, Kamper AL, Strandgaard S. Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008, 23:594-600.
16. Chan MY, Lin M, Lucas J, Moseley A, Thompson JW, Cyr D, Ueda H, Kajikawa M, Ortel TL, Becker RC. Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. Thromb Haemost 2012, 108:1180-1191. 10.1160/TH12-05-0310, 23052711.
17. Kaur P, Rizk NM, Ibrahim S, Younes N, Uppal A, Dennis K, Karve T, Blakeslee K, Kwagyan J, Zirie M, Ressom HW, Cheema AK. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. J Proteom Res 2012, 11:5527-5539.
18. Neiman M, Hedberg JJ, Dönnes PR, Schuppe-Koistinen I, Hanschke S, Schindler R, Uhlén M, Schwenk JM, Nilsson P. Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment. J Proteom Res 2011, 10:4925-4934.
19. Sjøland JA, Sidelmann JJ, Braband M, Pedersen RS, Esbensen K, Standeven KF, Ariëns RA, Gram J. Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost 2007, 98:339-345.
20. Koyama H, Nishizawa Y. AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?. Eur J Clin Invest 2010, 40:623-635. 10.1111/j.1365-2362.2010.02298.x, 20497213.
21. Thornalley PJ, Rabbani N. Protein damage in diabetes and uremia-identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect. Free Radic Res 2011, 45:89-100. 10.3109/10715762.2010.534162, 21110784.
22. O'Rourke MF, Hashimoto J. Arterial stiffness - A modifiable cardiovascular risk factor?. J Cardiopulm Rehabil Prev 2008, 28:225-237.
23. Denardo SJ, Nandyala R, Freeman GL, Pierce GL, Nichols WW. Pulse wave analysis of the aortic pressure waveform in severe left ventricular systolic dysfunction. Circ Heart Fail 2010, 3:149-156. 10.1161/CIRCHEARTFAILURE.109.862383, 19903930.
24. Reinhard H, Nybo M, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rasmussen LM, Rossing P, Jacobsen PK. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. Cardiovasc Diabetol 2011, 10:70. 10.1186/1475-2840-10-70, 3162489, 21801376.
25. Poulsen MK, Nybo M, Dahl J, Hosbond S, Poulsen TS, Johansen A, Høilund-Carlsen PF, Beck-Nielsen H, Rasmussen LM, Henriksen JE. Plasma osteoprotegrin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. Cardiovasc Diabetol 2011, 10:76. 10.1186/1475-2840-10-76, 3163516, 21838881.
26. Reinhard H, Lajer M, Gall MA, Tarnow L, Parving HH, Rasmussen LM, Rossing P. Osteoprotegerin and mortality in type 2 Diabetic patients. Diabetes Care 2010, 33:2561-2566. 10.2337/dc10-0858, 2992191, 20929997.
27. Venuraju SM, Yerramasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol 2010, 55:2049-2061. 10.1016/j.jacc.2010.03.013, 20447527.
28. Garcia A, Eiras S, Parguina AF, Alonso J, Rosa I, Salgado-Somoza A, Rico TY, Teijeira-Fernandez E, Gonzales-Juanatey JR. High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation. Int J Cardiol 2011, 150:283-290. 10.1016/j.ijcard.2010.04.036, 20451270.